Propel Bio Management’s Trevi Therapeutics TRVI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-260,000	Closed	-$775K	–	25
2024 Q2	$775K	Hold	260,000	–	–	0.5%	20
2024 Q1	$897K	Buy	+260,000	New	+$897K	0.52%	22